## Background: The role of intensive conventional dose chemotherapy in advanced low grade non-hodgkin's lymphomas is a matter of debate. the gruppo italiano per lo studio dei linfomi conducted a study to evaluate the efficacy and toxicity of a third-generation polychemotherapeutic regimen, promace-
โฆ LIBER โฆ
Determinants of the optimal first-line therapy for follicular lymphoma: A decision analysis
โ Scribed by Rebecca L. Olin; Peter A. Kanetsky; Thomas R. Ten Have; Sunita D. Nasta; Stephen J. Schuster; Charalambos Andreadis
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 165 KB
- Volume
- 85
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
A pilot study on the use of the proMACE-
โ
Luca Baldini; Andrea Guffanti; Paolo Gobbi; Mariangela Colombi; Massimo Federico
๐
Article
๐
1997
๐
John Wiley and Sons
๐
English
โ 90 KB
๐ 2 views
Anastrozole is superior to tamoxifen as
โ
Jacques Bonneterre; Aman Buzdar; Jean-Marc A. Nabholtz; John F. R. Robertson; Be
๐
Article
๐
2001
๐
John Wiley and Sons
๐
English
โ 155 KB
๐ 2 views
Chronic myelogenous leukemia in nonlymph
โ
Stefano Sacchi; Hagop M. Kantarjian; Susan O'Brien; Jorge Cortes; Mary Beth Rios
๐
Article
๐
1999
๐
John Wiley and Sons
๐
English
โ 104 KB
๐ 2 views
## BACKGROUND. The prognoses of patients with chronic myelogenous leukemia in blastic phase (CML-BP) are extremely poor. Treatment of patients with nonlymphoid CML-BP is associated with very low response rates, a median survival of 2-3 months, and significant toxicities. The aim of this study was